The comparison of the Treg cells level between patients with SR and with non-SR.
Before the treatment (%)
During the follow-up phase (%)
The rapamycin group
The cyclosporine A group
, comparing the Treg cells level before the treatment to that during the follow-up phase in the rapamycin group.